Miltiadis Papathanassiou Selected Research

Miltiadis Papathanassiou Research Topics

3	Cataract (Cataracts) 02/2014 - 01/2011
2	Corneal Ulcer 01/2016 - 09/2011
2	Corneal Neovascularization 04/2013 - 03/2008
2	Macular Degeneration (Age-Related Maculopathy) 11/2010 - 01/2009
2	Cicatrix (Scar) 01/2009 - 03/2008
1	Keratitis 01/2016
1	Hypertrophy 11/2015
1	Corneal Edema 12/2013
1	Abscess 05/2013
1	Conjunctivitis 04/2011
1	Hypersensitivity (Allergy) 04/2011
1	Intraoperative Complications 01/2011
1	Epidermolysis Bullosa 01/2011
1	Retinal Perforations 01/2011
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2011
1	Blister (Bulla) 01/2011
1	Epiretinal Membrane (Epiretinal Membranes) 11/2010
1	Inflammation (Inflammations) 10/2010
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Cysts 09/2010
1	Endophthalmitis (Ophthalmia) 02/2009
1	Meretoja syndrome 01/2009
1	Disease Progression 01/2009
1	Type II Lattice Corneal Dystrophy 01/2009
1	Choroidal Neovascularization 01/2009
1	Burns 03/2008

2	Therapeutic UsesIBA 04/2013 - 01/2009
2	Bevacizumab (Avastin)FDA Link 04/2013 - 03/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 01/2009
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2016
1	Retinaldehyde (Retinal)IBA 11/2015
1	Carotenoids (Carotene)IBA 02/2014
1	CarbohydratesIBA 02/2014
1	CholesterolIBA 02/2014
1	VitaminsIBA 02/2014
1	Valacyclovir (Valtrex)FDA LinkGeneric 12/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2013
1	Coloring Agents (Dyes)IBA 05/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2011
1	EnzymesIBA 04/2011
1	Excipients (Suspending Agents)IBA 04/2011
1	Amine Oxidase (Copper-Containing)IBA 04/2011
1	pimagedine (aminoguanidine)IBA 04/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011
1	NitritesIBA 04/2011
1	Methylprednisolone FDA LinkGeneric 10/2010
1	Methotrexate (Mexate)FDA LinkGeneric 10/2010
1	SteroidsIBA 10/2010
1	exemestane (Aromasin)FDA Link 09/2010
1	Moxifloxacin (Avelox)FDA Link 02/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2009
1	Ranibizumab (Lucentis)FDA Link 01/2009
1	SolutionsIBA 03/2008
1	AlkaliesIBA 03/2008